Page 4 - Breakthrough Status News Today

Submitted to the fda came from hundreds of patients. If you had used ten patients, its like studying twins in a way because its all the same disease. So if they had used ten patients and given a kind of conditional approval, then everyone would have gotten the drug a lot faster possibly. So things like that, you know, could be in the are in the works. But its difficult to get them working. Jessica, youve outlined the fda is coming up with a new designation, a breakthrough designation status whic...

Experiment has been granted Breakthrough Status by the food and drug administration. Results in early tests at Duke University have been so remarkable the f. D. A. Wants to fast track the therapy to more patients. The treatment is audacious using the polio virus to kill glioblastoma, a vicious brain cancer that can kill in matter of months. For two years 60 minutes has been following the patients in the Clinical Trial. Its a hell of a thing to be told you have months to live when youre 20 years ...

Cancer research firm CG Oncology Inc., which has a novel treatment that’s been called a “game changer” for bladder cancer, is aiming for a $1 billion valuation when it goes public in the coming days.

Experts use a major depressive disorder (MDD) patient case to provide clinical insights on managing MDD, and how they would educate patients about their condition.

Experts continue their discussion of the first patient case, explaining how glutamate-modulating therapies could help improve his symptoms and outcomes.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud system as innovative and promising approach for treatment of recurrent glioblastoma Paris, France, June 22, 2022 – Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to tre...

Press release content from Business Wire. The AP news staff was not involved in its creation.

(Photo by Sebastian Kaulitzki/Getty Images) Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences. The startup and its CEO Ed Cox became one of the developing spaces many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimers symptoms treatment, with Cox chairing a handful of industry networking events through the following months. But despite t...